| Acquirer | Target | Price |
|---|---|---|
| Spark Therapeutics | Genable Technologies Ltd. | $15,151,000 |
| Compassus | Genesis' home health & hospice business | $84,000,000 |
| AbbVie Inc. | Global collaboration on immunology compounds | $595 million |
| EyeGate Pharmaceuticals | Jade Therapeutics | $3,355,000 |
| MEDNAX, Inc. | Pediatric ENT Institute of South Texas, P.A. | N/A |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
